白血病中CAR T免疫疗法和CD19动力学的数学模型:比较分析
Mathematical models for CAR T immunotherapy and CD19 dynamics in leukemia: a comparative analysis
AI总结:
研究白血病中CAR T免疫疗法和CD19动力学,开发结合常微分方程与偏微分方程的数学模型,能捕捉白血病群体演变,区分不同白血病细胞,通过比较和敏感性分析,为CAR T治疗策略优化及个性化提供基础
摘要:
嵌合抗原受体(CAR)T细胞疗法已成为复发或难治性血液系统恶性肿瘤的成功治疗方法,尤其是针对B细胞急性淋巴细胞白血病(B ALL),CD19靶向疗法已取得较高的初始缓解率。然而,治疗后复发仍是主要临床挑战,常与抗原逃逸机制和CD19⁻白血病细胞出现有关。因此,了解CAR T细胞与抗原表达动力学之间的相互作用对于提高治疗效果和患者长期预后至关重要。在这项工作中,我们开发并比较分析了描述白血病中CAR T免疫疗法和CD19动力学的新型数学模型。我们提出的框架结合了房室常微分方程(ODE)公式以及偏微分方程(PDE)系统。两种方法都能够捕捉免疫压力下白血病群体的演变,特别是模型明确区分了CD19⁺和CD19⁻白血病细胞,并纳入了由CAR T活性调节的双向表型转变。所开发的模型为研究CAR T细胞疗法中的治疗反应、耐药性和复发机制提供了具有生物学可解释性和计算效率的工具。我们比较了不同建模方法再现CD19抗原调节和CAR T疗效动力学的能力。我们还提出了敏感性分析以研究参数对模型动力学的影响。我们的工作有助于对抗原驱动的耐药性进行数学理解,并为未来白血病中CAR T治疗策略的优化和个性化提供基础。
英文摘要:
Chimeric Antigen Receptor (CAR) T cell therapy has emerged as a successful treatment for relapsed or refractory hematological malignancies, particularly for B cell Acute Lymphoblastic Leukemia (B ALL), where CD19 targeted therapies have achieved high initial remission rates. However, relapse after treatment remains a major clinical challenge, frequently associated with antigen escape mechanisms and the emergence of CD19$^-$ leukemic cells. Understanding the interaction between CAR T cells and antigen expression dynamics is, therefore, essential for improving therapeutic efficacy and long-term patient outcomes. In this work, we develop and comparatively analyze novel mathematical models describing CAR T immunotherapy and CD19 dynamics in leukemia. Our proposed framework combines compartmental ordinary differential equation (ODE) formulations as well as partial differential equation (PDE) systems. Both methods are able to capture the evolution of leukemic populations under immune pressure and, in particular, the models explicitly distinguish between CD19$^+$ and CD19$^-$ leukemic cells and incorporate bidirectional phenotypic transitions regulated by CAR T activity. The developed models provide biologically interpretable and computationally efficient tools for studying treatment response, resistance, and relapse mechanisms in CAR T cell therapy. We compare the ability of the different modeling approaches to reproduce CD19 antigen modulation and CAR T efficacy dynamics. We also propose sensitivity analyses to study the parameters' influence on the models' dynamics. Our work contributes to the mathematical understanding of antigen-driven resistance and offers a basis for future optimization and personalization of CAR T therapeutic strategies in leukemia.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。